These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8045026)

  • 1. Japanese healthcare system: in vitro diagnostic tests and reimbursements.
    Shimauchi A
    Clin Chem; 1994 Aug; 40(8):1663-7. PubMed ID: 8045026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in dental expenditures in Japan with a universal health insurance system.
    Sato Y; Fukai K; Kunori Y; Yoshioka E; Saijo Y
    PLoS One; 2023; 18(10):e0292547. PubMed ID: 37796959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects for national health expenditure in Japan].
    Sakoi M
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1337-46. PubMed ID: 10969587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the surgical health care system and future aspect of surgery].
    Hiki Y
    Nihon Geka Gakkai Zasshi; 2003 Apr; 104(4):349-55. PubMed ID: 12774745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problems of national health insurance reimbursement revision, especially for laboratory tests].
    Mori M
    Rinsho Byori; 1995 Jul; 43(7):660-4. PubMed ID: 7674537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update information for physicians on laboratory tests: recent progress in clinical laboratory testing. Topics: I. Generalities; 4. Japanese medical insurance and clinical laboratory testing].
    Furukawa T; Miyazawa Y
    Nihon Naika Gakkai Zasshi; 2011 Nov; 100(11):3193-200. PubMed ID: 22250410
    [No Abstract]   [Full Text] [Related]  

  • 7. National healthcare spending in the U.S. and Japan: national economic policy and implications for neurosurgery.
    Bean JR
    Neurol Med Chir (Tokyo); 2005 Jan; 45(1):18-24. PubMed ID: 15699616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological tests and the reimbursement of medical fees in Japan].
    Kazunari K; Yoneyama A
    Rinsho Byori; 2011 Oct; 59(10):952-7. PubMed ID: 22184878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-stratified analysis of the impact of hypertension on National Health Insurance Medical Expenditures in Ibaraki, Japan.
    Sairenchi T; Irie F; Izumi Y; Muto T
    J Epidemiol; 2010; 20(3):192-6. PubMed ID: 20208401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory diagnostics in light of massive changes in official health policies.
    Müller B
    Clin Chem; 1994 Aug; 40(8):1658-62. PubMed ID: 8045025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health insurance systems in Japan: a neurosurgeon's view.
    Ito M
    Neurol Med Chir (Tokyo); 2004 Dec; 44(12):617-28. PubMed ID: 15684593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan.
    Mamiya H; Igarashi A
    J Med Econ; 2022; 25(1):206-211. PubMed ID: 35060813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of laboratory medicine in medical care--from the point of view of a manager].
    Takahashi H
    Rinsho Byori; 2003 Sep; 51(9):871-7. PubMed ID: 14560655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health insurance and health policy in the Federal Republic of Germany.
    Reinhardt UE
    Health Care Financ Rev; 1981 Dec; 3(2):1-14. PubMed ID: 10309554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survey results of medical insurance reimbursement system for independent medical laboratories in Korea].
    Bae SY; Kwon JA; Kim JS; Yoon SY; Lee CK; Lee KN; Kim DW; Min WK; Cha YJ; Chae SL; Hwang YS
    Korean J Lab Med; 2007 Apr; 27(2):143-50. PubMed ID: 18094567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost analysis of procedural fee for percutaneous transluminal coronary angioplasty at six Japanese hospitals].
    Chino M
    J Cardiol; 2001 Feb; 37(2):83-90. PubMed ID: 11255699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microeconomics of introduction of a PET system based on the revised Japanese National Insurance reimbursement system].
    Abe K; Kosuda S; Kusano S; Nagata M
    Kaku Igaku; 2003 Nov; 40(4):451-5. PubMed ID: 14733110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic evaluation for the prevention of cervical cancer by vaccination--from perspective of health insurance society and industry].
    Kawabayashi Y; Furuno M; Uchida M; Kawana T
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):493-8. PubMed ID: 23848018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of lumbar fenestration surgery in the Japanese universal health insurance system.
    Fujimori T; Miwa T; Iwasaki M; Oda T
    J Orthop Sci; 2018 Nov; 23(6):889-894. PubMed ID: 30075994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.